Literature DB >> 34652341

Activation of the XBP1s/O-GlcNAcylation Pathway Improves Functional Outcome After Cardiac Arrest and Resuscitation in Young and Aged Mice.

Ran Li1, Yuntian Shen, Xuan Li, Liping Lu, Zhuoran Wang, Huaxin Sheng, Ulrike Hoffmann, Wei Yang.   

Abstract

ABSTRACT: After cardiac arrest (CA) and resuscitation, the unfolded protein response (UPR) is activated in various organs including the brain. However, the role of the UPR in CA outcome remains largely unknown. One UPR branch involves spliced X-box-binding protein-1 (XBP1s). Notably, XBP1s, a transcriptional factor, can upregulate expression of specific enzymes related to glucose metabolism, and subsequently boost O-linked β-N-acetylglucosamine modification (O-GlcNAcylation). The current study is focused on effects of the XBP1 UPR branch and its downstream O-GlcNAcylation on CA outcome. Using both loss-of-function and gain-of-function mouse genetic tools, we provide the first evidence that activation of the XBP1 UPR branch in the post-CA brain is neuroprotective. Specifically, neuron-specific Xbp1 knockout mice had worse CA outcome, while mice with neuron-specific expression of Xbp1s in the brain had better CA outcome. Since it has been shown that the protective role of the XBP1s signaling pathway under ischemic conditions is mediated by increasing O-GlcNAcylation, we then treated young mice with glucosamine, and found that functional deficits were mitigated on day 3 post CA. Finally, after confirming that glucosamine can boost O-GlcNAcylation in the aged brain, we subjected aged mice to 8 min CA, and then treated them with glucosamine. We found that glucosamine-treated aged mice performed significantly better in behavioral tests. Together, our data indicate that the XBP1s/O-GlcNAc pathway is a promising target for CA therapy.
Copyright © 2021 by the Shock Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34652341      PMCID: PMC9059164          DOI: 10.1097/SHK.0000000000001732

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.533


  41 in total

Review 1.  Chemical approaches to understanding O-GlcNAc glycosylation in the brain.

Authors:  Jessica E Rexach; Peter M Clark; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2008-02       Impact factor: 15.040

Review 2.  A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.

Authors:  Ligen Shi; Marcelo Rocha; Rehana K Leak; Jingyan Zhao; Tarun N Bhatia; Hongfeng Mu; Zhishuo Wei; Fang Yu; Susan L Weiner; Feifei Ma; Tudor G Jovin; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-07       Impact factor: 6.200

Review 3.  A walk through the progression of resuscitation medicine.

Authors:  Muhammad Shoaib; Lance B Becker
Journal:  Ann N Y Acad Sci       Date:  2020-10-10       Impact factor: 5.691

4.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

5.  XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Laurie H Glimcher
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

6.  Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.

Authors:  Gladys A Ngoh; Heberty T Facundo; Tariq Hamid; Wolfgang Dillmann; Natasha E Zachara; Steven P Jones
Journal:  Circ Res       Date:  2008-11-20       Impact factor: 17.367

Review 7.  Impaired capacity to restore proteostasis in the aged brain after ischemia: Implications for translational brain ischemia research.

Authors:  Zhuoran Wang; Wei Yang
Journal:  Neurochem Int       Date:  2018-12-29       Impact factor: 3.921

8.  Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.

Authors:  Yating He; Xiaofeng Ma; Daojing Li; Junwei Hao
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  O-GlcNAcylation Reduces Ischemia-Reperfusion-Induced Brain Injury.

Authors:  Jin-Hua Gu; Jianhua Shi; Chun-Ling Dai; Jian-Bin Ge; Yang Zhao; Yanxing Chen; Qian Yu; Zheng-Hong Qin; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

10.  MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.

Authors:  Maorong Jiang; Ran Li; Jingjun Lyu; Xuan Li; Wei Wang; Zhuoran Wang; Huaxin Sheng; Weiguo Zhang; Jörn Karhausen; Wei Yang
Journal:  J Neuroinflammation       Date:  2020-08-31       Impact factor: 8.322

View more
  2 in total

Review 1.  An update on the unfolded protein response in brain ischemia: Experimental evidence and therapeutic opportunities.

Authors:  Xuan Li; Wei Yang
Journal:  Neurochem Int       Date:  2021-10-31       Impact factor: 3.921

2.  Targeting O-GlcNAcylation in ischemic stroke.

Authors:  Xuan Li; Wei Yang
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.